Post-traumatic neurodegeneration and chronic traumatic encephalopathy

Molecular and Cellular Neurosciences
Daniel H DaneshvarAnn C McKee

Abstract

Traumatic brain injury (TBI) is a leading cause of mortality and morbidity around the world. Concussive and subconcussive forms of closed-head injury due to impact or blast neurotrauma represent the most common types of TBI in civilian and military settings. It is becoming increasingly evident that TBI can lead to persistent, long-term debilitating effects, and in some cases, progressive neurodegeneration and chronic traumatic encephalopathy (CTE). The epidemiological literature suggests that a single moderate-to-severe TBI may be associated with accelerated neurodegeneration and increased risk of Alzheimer's disease, Parkinson's disease, or motor neuron disease. However, the pathologic phenotype of these post-traumatic neurodegenerations is largely unknown and there may be pathobiological differences between post-traumatic disease and the corresponding sporadic disorder. By contrast, the pathology of CTE is increasingly well known and is characterized by a distinctive pattern of progressive brain atrophy and accumulation of hyperphosphorylated tau neurofibrillary and glial tangles, dystrophic neurites, 43 kDa TAR DNA-binding protein (TDP-43) neuronal and glial aggregates, microvasculopathy, myelinated axonopathy, neuroinflamma...Continue Reading

References

Mar 1, 1988·The American Journal of Forensic Medicine and Pathology·J B McQuillenP Morrow
Aug 1, 1968·Journal of Neurology, Neurosurgery, and Psychiatry·D R Oppenheimer
Jan 1, 1981·Neurosurgery·G L CliftonR G Grossman
Aug 1, 1995·Journal of Neurotrauma·D F MeaneyT A Gennarelli
Jul 1, 1996·Acta Neurologica Scandinavica·D StricklandR I Roelofs
Jul 9, 1997·JAMA : the Journal of the American Medical Association·B D JordanS Gandy
Aug 12, 1999·Acta Neuropathologica·J F GeddesT Révész
Apr 4, 2000·Neurology·Z GuoL A Farrer
Jun 7, 2000·Neuropathology and Applied Neurobiology·K HorsburghJ A Nicoll
May 29, 2003·Neurology·J H BowerW A Rocca
Jun 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·S FlemingerA Giora
Nov 26, 2003·Experimental Neurology·K UryuJ Q Trojanowski
Jun 26, 2004·Annual Review of Neuroscience·Lucie I BruijnDon W Cleveland
Oct 30, 2004·Medicine and Science in Sports and Exercise·Vincent J MieleJulian E Bailes
Jan 7, 2005·Brain : a Journal of Neurology·Adriano ChiòGabriele Mora
Jan 18, 2005·Nature Genetics·Hreinn StefanssonKari Stefansson
Jun 1, 2005·European Journal of Epidemiology·Stefano Belli, Nicola Vanacore
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Giuseppina AmadoroNadia Canu
Jun 5, 2007·Medicine and Science in Sports and Exercise·Kevin M GuskiewiczRobert C Cantu
Jun 27, 2007·The American Journal of Pathology·Nigel J CairnsIan R A Mackenzie
Jun 29, 2007·Neuro-degenerative Diseases·Laura GaspariniMaria Grazia Spillantini
Jul 21, 2007·American Journal of Epidemiology·Honglei ChenFreya Kamel
Sep 20, 2007·Annals of Neurology·Joshua A SonnenThomas J Montine
Jun 19, 2009·Journal of Neuropathology and Experimental Neurology·Ann C McKeeRobert A Stern
Aug 26, 2009·CNS & Neurological Disorders Drug Targets·Rodrigo MoralesClaudio Soto
Nov 20, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Alessandra BinazziUNKNOWN ALS Rome Group
Feb 5, 2010·Journal of the Neurological Sciences·Silke SchmidtEugene Z Oddone
Aug 14, 2010·Current Alzheimer Research·J VandrovcovaR de Silva
Aug 20, 2010·Journal of Neuropathology and Experimental Neurology·Ann C McKeeAndrew E Budson
Oct 13, 2010·Journal of Geriatric Psychiatry and Neurology·Lynn M BekrisCyrus P Zabetian
Nov 16, 2010·Clinics in Sports Medicine·Daniel H DaneshvarRobert C Cantu

❮ Previous
Next ❯

Citations

May 6, 2015·British Journal of Pharmacology·Alan I FadenDavid J Loane
Aug 4, 2015·Journal of Neurochemistry·Colin K Combs
Nov 28, 2015·Current Opinion in Pharmacology·Nikolaus Plesnila
Dec 22, 2015·Seminars in Nuclear Medicine·Laura B EisenmengerJames M Mountz
Dec 18, 2015·Psychosomatics·Davin K QuinnRonald A Yeo
Dec 1, 2015·Journal of Neuroimmunology·Mansoureh EslamiMahmoudreza Hadjighassem
Oct 8, 2015·Trends in Neurosciences·Kristina G WitcherJonathan P Godbout
Apr 2, 2016·Neurosurgical Focus·Jonathan G HobbsJulian E Bailes
May 15, 2016·Journal of Neurotrauma·William J DurhamBrent E Masel
Oct 6, 2016·Nutritional Neuroscience·Brandon P Lucke-WoldCharles L Rosen
Oct 30, 2016·Acta Neuropathologica Communications·Jonathan D CherryThor D Stein
Nov 7, 2016·Journal of Neuropathology and Experimental Neurology·Shawna NoyMarc R Del Bigio
Mar 4, 2017·World Neurosurgery·Kenneth PerrinePhilip Stieg
Jul 13, 2017·Traffic Injury Prevention·Saksham GuptaKee B Park
Apr 13, 2018·Journal of Neurotrauma·Rachael S AllenMachelle T Pardue
Jan 27, 2018·Journal of Neurosurgery·Gentian ToshkeziLi-Ru Zhao
Oct 10, 2018·Journal of Neuropathology and Experimental Neurology·Gabriel S WaltThor D Stein
Feb 12, 2019·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yevgen ChornenkyyPeter T Nelson
Nov 2, 2019·Brain : a Journal of Neurology·Grant L IversonRudolph J Castellani
Dec 25, 2019·Neurology·Christopher D Anderson, Jonathan Rosand
Oct 31, 2019·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Grant L Iverson
Nov 9, 2019·The American Journal of Sports Medicine·Lily N TrinhMary K Mulcahey
Aug 27, 2017·BMC Neurology·Jian-Ming LiXiao-Xin Yan
Jun 17, 2020·BMJ Open Sport & Exercise Medicine·Julia CampbellJonathan Olshaker
May 19, 2017·Concussion·Kelly M McAteerFrances Corrigan
Feb 15, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Yosuke Akamatsu, Khalid A Hanafy
Jan 22, 2019·Journal of Alzheimer's Disease : JAD·Donna J CrossDavid G Cook
Sep 29, 2019·Stem Cells and Development·Samantha L DelaneyAllen L Ho
May 4, 2017·Journal of Neuroscience Research·Yuri Zilberter, Misha Zilberter
Jul 6, 2018·Frontiers in Neurology·Kristen D KelleyIrene Litvan
Jul 3, 2020·Proceedings of the National Academy of Sciences of the United States of America·Janani SaikumarNancy M Bonini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Related Papers

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Ann C McKee, Meghan E Robinson
Handbook of Clinical Neurology
Ann C McKee, Daniel H Daneshvar
Current Neurology and Neuroscience Reports
Jesse MezAnn C McKee
© 2022 Meta ULC. All rights reserved